Investment Rating - The report maintains a "Buy" rating for the company with a target price of HKD 7.90 [6]. Core Insights - The company reported a revenue of HKD 54.3 billion for 2025, a decrease of 2.1% year-on-year, while core profit increased by 4% to HKD 6.0 billion, aligning with expectations [1]. - The company plans to maintain a stable dividend policy with a payout of HKD 0.35, resulting in a dividend yield of approximately 4.8% [1]. - The report highlights the company's strong energy security advantages and the profitability turning point for green fuel business, supporting the investment thesis [1]. Summary by Sections Hong Kong Gas - In 2025, Hong Kong gas sales remained stable at 27,181 TJ, with residential gas consumption increasing due to lower average temperatures, offsetting slight declines in commercial and industrial gas usage [2]. - The company added 20,000 new customers, benefiting from the Northern Metropolis Development Plan, which aims to provide over 500,000 residential units over 20 years, potentially increasing gas demand [2]. - The EBITDA margin for Hong Kong is expected to remain around 50% in 2026 [2]. Mainland City Gas - In 2025, mainland city gas sales volume was 36.35 billion cubic meters, remaining flat year-on-year, with slight growth in residential gas due to old community renovations and new user connections [3]. - The gas price difference improved to RMB 0.54 per cubic meter, driven entirely by residential gas price increases, with a price adjustment coverage rate of 90% [3]. - The report anticipates a further increase in the city gas price difference to RMB 0.56 per cubic meter in 2026 [3]. Green Fuel - The sustainable aviation fuel (SAF) production capacity is expected to reach 770,000 tons by the end of 2025, with significant price increases observed in SAF and HVO since the beginning of the year [4]. - The green methanol strategy aligns with policy cycles, with the Foshan plant expected to start production by the end of 2027, matching the implementation of IMO shipping emission reduction targets [4]. - The report projects a sales target of 40,000 tons for green methanol in 2026, catering to shipping and green chemical demands [4]. Free Cash Flow and Valuation - The report suggests that the company's free cash flow is likely to exceed expectations, with a target price adjustment to HKD 7.90, reflecting a 19% premium over the historical average [5][29]. - The company’s estimated net profit for 2026-2028 is projected at HKD 6.09 billion, HKD 6.45 billion, and HKD 6.77 billion, respectively [5]. - The report adjusts the valuation to 2.5x PB for 2026, maintaining the previous year's multiple, indicating confidence in the company's growth potential [5][29].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Insights - The company reported a revenue of 14.26 billion yuan for 2025, representing a year-on-year growth of 20.83%. The net profit was 1.06 billion yuan, down 18.37% year-on-year, but the adjusted net profit was 1.53 billion yuan, up 1.3% year-on-year [7] - The HNB (Heat Not Burn) business is expected to ramp up, with significant growth in the electronic atomization segment. The company is also expanding into new business areas such as medical and beauty atomization, which are anticipated to provide long-term growth opportunities [7] - The company is positioned as a global leader in atomization technology, with a multi-business matrix that is steadily advancing despite tightening regulatory policies [7] Financial Summary - Total revenue projections for the company are as follows: - 2024: 11.80 billion yuan - 2025: 14.26 billion yuan - 2026: 16.62 billion yuan - 2027: 19.77 billion yuan - 2028: 23.34 billion yuan - The projected net profit for the years 2026 to 2028 is as follows: - 2026: 1.26 billion yuan - 2027: 1.88 billion yuan - 2028: 2.79 billion yuan - The earnings per share (EPS) is projected to be: - 2024: 0.21 yuan - 2025: 0.17 yuan - 2026: 0.20 yuan - 2027: 0.30 yuan - 2028: 0.45 yuan [1][8]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The approval of the first type I recombinant collagen for medical aesthetics opens new growth opportunities for the company, with expectations for a performance recovery in 2026 [1] - The company reported a revenue of 55.2 billion yuan in 2025, a slight decrease of 0.4% year-on-year, and a net profit attributable to shareholders of 19.15 billion yuan, down 7.2% year-on-year [8] - The company has adjusted its profit forecasts for 2026-2027 due to increased industry competition and short-term impacts on sales, with net profits expected to be 19.8 billion yuan in 2026 and 22.7 billion yuan in 2027 [1] Financial Performance Summary - Revenue projections for 2024A to 2028E are as follows: 5,539 million yuan (2024A), 5,519 million yuan (2025A), 6,034 million yuan (2026E), 6,917 million yuan (2027E), and 8,292 million yuan (2028E) [1] - Net profit attributable to shareholders is projected to be 2,062 million yuan (2024A), 1,915 million yuan (2025A), 1,978 million yuan (2026E), 2,270 million yuan (2027E), and 2,658 million yuan (2028E) [1] - The company's earnings per share (EPS) is expected to be 1.93 yuan (2024A), 1.79 yuan (2025A), 1.85 yuan (2026E), 2.12 yuan (2027E), and 2.48 yuan (2028E) [1] - The current price-to-earnings (P/E) ratio is 14.10 for 2024A, 15.19 for 2025A, 14.70 for 2026E, 12.81 for 2027E, and 10.94 for 2028E [1]

Investment Rating - The report maintains an "Outperform" rating for the company [1]. Core Insights - The company reported better-than-expected performance for 2025, with revenue growth of 3% to 296 billion RMB and a net profit decline of 3% to 29.4 billion RMB, primarily driven by professional sports categories and effective cost control [4]. - The company expects high single-digit revenue growth for 2026, with improvements in gross margin due to enhanced brand and product strength, although expenses are anticipated to rise due to Olympic sponsorship and new channel development [4]. Financial Data and Profit Forecast - Revenue projections (in billion RMB): - 2024: 287 - 2025: 296 - 2026E: 317 - 2027E: 337 - 2028E: 353 [2] - Net profit projections (in billion RMB): - 2024: 30.1 - 2025: 29.4 - 2026E: 28.5 - 2027E: 31.6 - 2028E: 34.0 [2] - Gross margin is expected to be around 49% for 2026, with a slight improvement anticipated in subsequent years [4]. - The company’s PE ratios are projected to be 17 for 2026, 15 for 2027, and 14 for 2028 [4]. Operational Performance - The company maintained a healthy inventory turnover ratio and product age structure, with a sell-through rate for new products between 70% and 80% [4]. - Professional categories such as running, cross-training, and badminton led growth, while basketball and lifestyle segments saw declines [4]. - E-commerce performance outpaced offline sales, with a total of 6,091 stores by the end of 2025, reflecting a strategic focus on channel innovation [4].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Insights - The approval of the first type I recombinant collagen for medical aesthetics opens new growth opportunities for the company, with expectations for performance recovery in 2026 [1] - The company reported a total revenue of 55.19 billion yuan in 2025, a slight decrease of 0.37% year-on-year, and a net profit attributable to shareholders of 19.15 billion yuan, down 7.15% year-on-year [8] - The company has adjusted its profit forecasts for 2026 and 2027 downwards due to increased industry competition and short-term impacts on sales, with new profit estimates of 19.8 billion yuan and 22.7 billion yuan respectively [1] Financial Performance Summary - Revenue projections for the company are as follows: 2024A: 55.39 billion yuan, 2025A: 55.19 billion yuan, 2026E: 60.34 billion yuan, 2027E: 69.17 billion yuan, 2028E: 82.92 billion yuan [1] - Net profit projections are: 2024A: 20.62 billion yuan, 2025A: 19.15 billion yuan, 2026E: 19.78 billion yuan, 2027E: 22.70 billion yuan, 2028E: 26.58 billion yuan [1] - The company's earnings per share (EPS) are projected to be: 2024A: 1.93 yuan, 2025A: 1.79 yuan, 2026E: 1.85 yuan, 2027E: 2.12 yuan, 2028E: 2.48 yuan [1] - The price-to-earnings (P/E) ratios for the current price and latest diluted EPS are: 2024A: 14.10, 2025A: 15.19, 2026E: 14.70, 2027E: 12.81, 2028E: 10.94 [1]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Insights - The company reported a revenue of 14.26 billion yuan for 2025, representing a year-on-year growth of 20.83%. However, the net profit was 1.06 billion yuan, down 18.37% year-on-year. Adjusted net profit was 1.53 billion yuan, showing a slight increase of 1.3% [7] - The HNB (Heat Not Burn) business is expected to ramp up, while the electronic atomization segment is recovering steadily. The company is expanding its product matrix and has launched HNB products in various international markets, aiming for increased market share [7] - The company is positioned as a global leader in atomization technology, with ongoing growth opportunities in electronic atomization and new business ventures in medical and beauty atomization [7] Financial Projections - Total revenue projections for the company are as follows: 2024A: 11.8 billion yuan, 2025A: 14.26 billion yuan, 2026E: 16.62 billion yuan, 2027E: 19.77 billion yuan, and 2028E: 23.34 billion yuan [1] - The projected net profit for 2026 is 1.26 billion yuan, with further increases expected in subsequent years, reaching 2.78 billion yuan by 2028 [1] - The earnings per share (EPS) is forecasted to be 0.21 yuan for 2024, decreasing to 0.17 yuan for 2025, and then gradually increasing to 0.45 yuan by 2028 [1] Business Performance - The company’s self-owned brand and B2B business segments reported revenues of 29.12 billion yuan and 113.44 billion yuan respectively, with year-on-year growth rates of 17.6% and 21.7% [7] - The HNB revenue reached 12.87 billion yuan, showing a significant year-on-year increase of 475.4%, while European and American atomization revenues grew by 18.5% and 2.1% respectively [7] - The adjusted net profit margin for the second half of 2025 was 9.6%, with a year-on-year decrease of 1.6 percentage points, indicating a narrowing decline compared to the first half [7]

Investment Rating - The report maintains a "Buy" rating for Weimeng Group (2013.HK) [4] Core Insights - Weimeng Group achieved a revenue of 1.592 billion RMB in 2025, representing a year-on-year increase of 18.9%, primarily driven by a significant rise in merchant solutions revenue [1] - The company reported a gross profit of 1.195 billion RMB, with a gross margin of 75.1%, an increase of 30.6 percentage points year-on-year [1] - Adjusted net profit for 2025 was 42 million RMB, marking the first profit since 2021, attributed to cost reduction and efficiency improvements [1] Summary by Relevant Sections Subscription Revenue - Subscription solutions revenue for 2025 was 897 million RMB, down 2.3% year-on-year, due to the company's decision to cut low-quality subscription services [2] - The number of paying merchants decreased to 58,400, a decline of 7.2% year-on-year, while the average revenue per user (ARPU) increased by 5.27% to 15,367 RMB [2] - The smart retail business generated 598 million RMB in revenue, accounting for 66.6% of subscription solutions revenue, with a recovery in revenue expected in the second half of 2025 [2] Merchant Solutions - Merchant solutions revenue reached 695 million RMB, up 65.1% year-on-year, due to the recovery of rebate ratios from the advertising platform [3] - The company adjusted its client structure, reducing low-margin and high-risk clients, leading to a decrease in gross advertising revenue to approximately 16.694 billion RMB, down 7.33% year-on-year [3] - The gross margin for merchant solutions business improved to 91% compared to 63% in 2024 [3] AI Expansion - AI product revenue was approximately 116 million RMB in 2025, with five major products launched, covering various application scenarios [4] - The company strategically invested in a North American AI innovation company, Genstore.ai, to explore overseas business opportunities [4] Financial Forecast and Valuation - Revenue forecasts for 2026 and 2027 are set at 1.794 billion RMB and 1.996 billion RMB, respectively, with a new forecast for 2028 at 2.14 billion RMB [4] - The report indicates a gradual stabilization of the SaaS business and a strong expected growth in AI product revenue [4]

Investment Rating - The report maintains a "Buy" rating for ZTO Express (2057.HK) [3] Core Insights - ZTO Express has expanded its leading advantage and enhanced shareholder returns, with a commitment to return at least 50% of adjusted net profit to shareholders starting in 2026, including dividends and buybacks [9] - The company reported a net profit of 9.24 billion RMB for 2025, a year-on-year increase of 3.9%, while the adjusted net profit was 9.51 billion RMB, a decrease of 6.3% [9] - The total business volume for 2025 reached 38.52 billion pieces, a 13.2% increase year-on-year, maintaining a market share of 19.4% [9] Financial Forecasts - Revenue projections for ZTO Express are as follows: - 2025: 49.1 billion RMB - 2026: 56.9 billion RMB (growth rate of 16.0%) - 2027: 62.0 billion RMB (growth rate of 8.9%) - 2028: 66.3 billion RMB (growth rate of 6.9%) [2] - The expected net profit for the years 2026-2028 is projected to be: - 2026: 11.37 billion RMB - 2027: 12.92 billion RMB - 2028: 13.98 billion RMB [2] - Earnings per share (EPS) are forecasted to be: - 2026: 14.76 RMB - 2027: 16.78 RMB - 2028: 18.16 RMB [2] Operational Performance - The average revenue per package for 2025 was 1.25 RMB, a slight decrease from the previous year, while the average revenue per package in Q4 2025 was 1.35 RMB, showing a year-on-year increase [9] - The total cost per package for 2025 was 0.94 RMB, with a slight increase from the previous year, while the cost in Q4 2025 was 1.01 RMB [9] - The company has successfully avoided intense price competition due to the "anti-involution" policy, leading to a recovery in package revenue [9] Market Position - ZTO Express's market share in Q4 2025 was 19.6%, reflecting a year-on-year increase of 0.8 percentage points, indicating a return to growth in market share [9] - The company completed 10.56 billion packages in Q4 2025, a 9.2% increase year-on-year, demonstrating resilience in its business volume [9]

Investment Rating - The report maintains a "Buy" rating for the company, anticipating significant growth in the next 6-12 months [5]. Core Insights - The company reported a revenue of 29.6 billion RMB for the year, reflecting a year-on-year increase of 3.2%, with a net profit of 2.94 billion RMB and a net profit margin of 9.9% [2]. - The second half of the year saw revenue growth of 3.1% to 14.78 billion RMB and a net profit increase of 13.0% to 1.20 billion RMB, indicating better-than-expected performance [2]. - The company is expected to achieve high single-digit revenue growth in 2026, driven by new products and channels, with a projected net profit of 3.23 billion RMB [4][5]. Summary by Sections Performance Review - The company achieved a revenue of 29.6 billion RMB in 2025, a 3.2% increase year-on-year, with a net profit of 2.94 billion RMB and a net profit margin of 9.9% [2]. - The second half of the year saw revenue growth of 3.1% to 14.78 billion RMB, with net profit increasing by 13.0% to 1.20 billion RMB, surpassing expectations [2]. Operational Analysis - Revenue from direct channels slightly decreased by 3.3% due to optimization adjustments, resulting in a net reduction of 59 stores to 1,238, while store efficiency improved [3]. - The distribution channel revenue grew by 6.3%, with a notable acceleration in the second half, and the number of franchise stores increased by 33 to 4,853 [3]. - E-commerce revenue grew by 5.3%, with improved online traffic and conversion rates [3]. Cost Control and Profitability - The company's gross margin decreased by 0.4 percentage points to 49.0%, but this was better than expected, with sales expense ratio declining by 1.03 percentage points to 31.05% [4]. - The net profit margin was impacted by an increase in the effective tax rate, decreasing by 0.6 percentage points to 9.9% [4]. Future Outlook - The company is expected to launch new products and channels in 2026, with projected revenue growth in high single digits and a net profit of 3.23 billion RMB [4]. - The introduction of new technologies and partnerships, such as the signing with COC, is anticipated to enhance brand influence and overall revenue growth [4].

Investment Rating - The report maintains a "Buy" rating for the company with a target price of HKD 7.90 [6]. Core Insights - The company reported a revenue of HKD 54.3 billion for 2025, a decrease of 2.1% year-on-year, while core profit increased by 4% to HKD 6.0 billion, aligning with expectations [1]. - The company is expected to benefit from a stable energy supply and cost-locking mechanisms, which will help maintain profit margins [2]. - The green fuel segment is anticipated to see a profit increase in 2026 due to rising prices and capacity growth [4]. - The company is undergoing a light-asset transformation that is expected to improve free cash flow [5]. Summary by Sections Hong Kong Gas - The gas sales volume in Hong Kong remained stable at 27,181 TJ in 2025, with a slight increase in residential gas consumption offsetting a minor decline in commercial and industrial usage [2]. - The company added 20,000 new customers, supported by the Northern Metropolis Action Plan, which aims to provide over 500,000 residential units over the next 20 years [2]. Mainland City Gas - The sales volume of city gas in mainland China was 36.35 billion cubic meters in 2025, remaining flat year-on-year [3]. - The city gas price differential improved to RMB 0.54 per cubic meter, driven entirely by an increase in residential gas prices [3]. Green Fuel - The production capacity for sustainable aviation fuel (SAF) is expected to reach 770,000 tons by the end of 2025, with significant price increases observed in SAF and hydrotreated vegetable oil (HVO) [4]. - The green methanol strategy aligns with policy cycles, with production expected to start in 2027 [4]. Financial Projections - The company expects net profit attributable to shareholders to be HKD 6.09 billion in 2026, reflecting a 7% increase from 2025 [10]. - The target price of HKD 7.90 represents a 19% premium over the historical average price-to-book ratio of 2.1x [5][29].